Business Description
Odyssey Therapeutics is a Boston-based drug development company focused on creating new treatments for autoimmune and inflammatory conditions. Founded in 2021, the company is advancing several experimental therapies, including oral pills and protein-based drugs that target the biological pathways driving diseases like ulcerative colitis. Its most advanced candidate is currently being tested in a mid-stage clinical trial, with several other treatments at earlier stages of development.
